The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area
Open accessAbstract
Significance: Hypocretin (orexin) and dynorphin are neuromodulators that play an important role in regulating affect and motivation. Orexin is critical for reward and is implicated in drug seeking, whereas dynorphin mediates negative mood and is implicated in depressive-like states. Considering these opposing effects, reports that both peptides are expressed in the same neurons and are coreleased are counterintuitive. Here, we demonstrate that orexin and dynorphin are coexpressed within the same synaptic vesicles and that this colocalization has a profound influence on reward, drug taking, and impulsive-like behavior. The fact that orexin occludes the depressive-like antireward effects of dynorphin significantly changes how we view the functional role of orexin in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 2×
“It is produced primarily within the hypothalamus (7), and acts at orexin 1 receptor (OX1R) and OX2R (also known as Hcrt-R1 and Hcrt-R2), which are expressed in many brain areas, including the ventral tegmental area (VTA) of the midbrain (8).”
BackgroundDifferential expression of orexin receptors 1 and 2 in the rat brain
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., & Elmquist, J. K. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1190 · Cited by 1,659
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Impulsivity as a determinant and consequence of drug use: a review of underlying processes
de Wit, H. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00129.x · Cited by 1,415
Neural substrates of awakening probed with optogenetic control of hypocretin neurons
Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K., & de Lecea, L. (2007) · Nature · doi:10.1038/nature06310 · Cited by 1,341
A role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311 · cited 5×
“Orexin-dynorphin neurons express increased levels of the immediate early gene c-Fos in response to rewards and reward-predictive cues (4, 6, 22), indicating high levels of neuronal activation that favor neuropeptide release.”
BackgroundResultInfluentialThe 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
The Guide for the Care and Use of Laboratory Animals
(2016) · ILAR Journal · doi:10.1093/ilar/ilw013 · Cited by 945
Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., & Bonci, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.016 · Cited by 718 · cited 3×
“These concentrations were previously found to exert saturating effects on VTA cell activity (5, 52).”
BackgroundSelf-citationHabenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663
Self-citationExcitation of Ventral Tegmental Area Dopaminergic and Nondopaminergic Neurons by Orexins/Hypocretins
Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L., & Brown, R. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00007.2003 · Cited by 583
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544 · cited 2×
“enous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal”
BackgroundBals-Kubik, R., Ableitner, A., Herz, A., & Shippenberg, T. S. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10296-6 · Cited by 524
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507480102 · Cited by 520
Self-citationNarita, M., Nagumo, Y., Hashimoto, S., Narita, M., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2761-05.2006 · Cited by 516
Fadel, J., & Deutch, A. Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00017-9 · Cited by 503
Bari, A., Dalley, J. W., & Robbins, T. W. (2008) · Nature Protocols · doi:10.1038/nprot.2008.41 · Cited by 452
Orexin (Hypocretin) Neurons Contain Dynorphin
Chou, T. C., Lee, C. E., Lu, J., Elmquist, J. K., Hara, J., Willie, J. T., Beuckmann, C. T., Chemelli, R. M., Sakurai, T., Yanagisawa, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-j0003.2001 · Cited by 429
The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398
The orexin system regulates alcohol-seeking in rats
Lawrence, A. J., Cowen, M. S., Yang, H., Chen, F., & Oldfield, B. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706789 · Cited by 392
Dynorphin and the pathophysiology of drug addiction
Shippenberg, T. S., Zapata, A., & Chefer, V. I. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.011 · Cited by 387 · cited 2×
“enous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal”
BackgroundHeterosynaptic Dopamine Neurotransmission Selects Sets of Corticostriatal Terminals
Bamford, N. S., Zhang, H., Schmitz, Y., Wu, N.-P., Cepeda, C., Levine, M. S., Schmauss, C., Zakharenko, S. S., Zablow, L., & Sulzer, D. (2004) · Neuron · doi:10.1016/s0896-6273(04)00265-x · Cited by 373
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation
Carlezon, W. A., & Chartoff, E. H. (2007) · Nature Protocols · doi:10.1038/nprot.2007.441 · Cited by 367
Self-citationOrexin A/Hypocretin-1 Selectively Promotes Motivation for Positive Reinforcers
Borgland, S. L., Chang, S.-J., Bowers, M. S., Thompson, J. L., Vittoz, N., Floresco, S. B., Chou, J., Chen, B. T., & Bonci, A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6096-08.2009 · Cited by 341
Self-citationKinase cascades and ligand-directed signaling at the kappa opioid receptor
Bruchas, M. R., & Chavkin, C. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1806-y · Cited by 317
Insular hypocretin transmission regulates nicotine reward
Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M., & Kenny, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808023105 · Cited by 296
Self-citationκ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-09981.2003 · Cited by 275
Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats
Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., & Carlezon, W. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1680-y · Cited by 273
Self-citationOrexin Signaling Mediates the Antidepressant-Like Effect of Calorie Restriction
Lutter, M., Krishnan, V., Russo, S. J., Jung, S., McClung, C. A., & Nestler, E. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5584-07.2008 · Cited by 234 · cited 1×
“As one example, orexin mRNA levels are decreased following a type of chronic social stress that results in a depressive-like phenotype in mice (48) and rats (49).”
BackgroundWinstanley, C. A., Olausson, P., Taylor, J. R., & Jentsch, J. D. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01215.x · Cited by 232
Orexin/hypocretin signaling at the orexin 1 receptor regulates cue‐elicited cocaine‐seeking
Smith, R. J., See, R. E., & Aston‐Jones, G. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06844.x · Cited by 218
kappa-Opioid receptor signaling and brain reward function
Bruijnzeel, A. W. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.008 · Cited by 214 · cited 2×
“enous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal”
BackgroundA Role for Hypocretin (Orexin) in Male Sexual Behavior
Muschamp, J. W., Dominguez, J. M., Sato, S. M., Shen, R.-Y., & Hull, E. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4121-06.2007 · Cited by 193
Self-citationSmart, D., Jerman, J. C., Brough, S. J., Rushton, S. L., Murdock, P. R., Jewitt, F., Elshourbagy, N. A., Ellis, C. E., Middlemiss, D. N., & Brown, F. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702780 · Cited by 188
Development of κ Opioid Receptor Antagonists
Carroll, F. I., & Carlezon, W. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301783x · Cited by 185
Self-citation1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor
Porter, R. A., Chan, W. N., Coulton, S., Johns, A., Hadley, M. S., Widdowson, K., Jerman, J. C., Brough, S. J., Coldwell, M., Smart, D., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00343-2 · Cited by 159
Li, Y., & van den Pol, A. N. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3380-06.2006 · Cited by 157
Mahler, S. V., Smith, R. J., & Aston‐Jones, G. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2681-5 · Cited by 149
Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1688-3 · Cited by 143
Moorman, D. E., & Aston‐Jones, G. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2871-10.2010 · Cited by 129
A Novel Procedure for Pre-embedding Double Immunogold–Silver Labeling at the Ultrastructural Level
Yi, H. L., Leunissen, J. L. M., Shi, G.-M., Gutekunst, C., & Hersch, S. M. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900301 · Cited by 119
Role of orexin/hypocretin in dependence and addiction
Sharf, R., Sarhan, M., & Dileone, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.028 · Cited by 117
Nocjar, C., Zhang, J., Feng, P., & Panksepp, J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.033 · Cited by 114
Orexin Signaling Via the Orexin 1 Receptor Mediates Operant Responding for Food Reinforcement
Sharf, R., Sarhan, M., Brayton, C. E., Guarnieri, D. J., Taylor, J. R., & Dileone, R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.035 · Cited by 112
Potter, D. N., Damez-Werno, D. M., Carlezon, W. A., Cohen, B. M., & Chartoff, E. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.021 · Cited by 95
Self-citationHollander, J. A., Pham, D., Fowler, C. D., & Kenny, P. J. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00047 · Cited by 94
Self-citationKappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents
Ford, C., Beckstead, M. J., & Williams, J. T. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00963.2006 · Cited by 93
McGregor, R., Wu, M., Barber, G., Ramanathan, L., & Siegel, J. M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4017-11.2011 · Cited by 93
The Kappa-Opioid Agonist U69,593 Blocks Cocaine-Induced Enhancement of Brain Stimulation Reward
Tomasiewicz, H. C., Todtenkopf, M. S., Chartoff, E. H., Cohen, B. M., & Carlezon, W. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.029 · Cited by 92
Self-citationA review on electron microscopy and neurotransmitter systems
Torrealba, F., & Carrasco, M. A. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.06.004 · Cited by 72
Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss–Webster mice
Riday, T. T., Fish, E. W., Robinson, J. E., Jarrett, T. M., McGuigan, M. M., & Malanga, C. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.003 · Cited by 19
Cited by
Motivational activation: a unifying hypothesis of orexin/hypocretin function
Mahler, S. V., Moorman, D. E., Smith, R. J., James, M. H., & Aston-Jones, G. (2014) · Nature Neuroscience · doi:10.1038/nn.3810 · Cited by 385
“Liking” and “wanting” in eating and food reward: Brain mechanisms and clinical implications
Morales, I., & Berridge, K. C. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113152 · Cited by 346
Functional consequences of neuropeptide and small-molecule co-transmission
Nusbaum, M. P., Blitz, D. M., & Marder, E. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.56 · Cited by 302
The neurobiological basis of narcolepsy
Mahoney, C. E., Cogswell, A., Koralnik, I. J., & Scammell, T. E. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0097-x · Cited by 289
Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour
Bonnavion, P., Mickelsen, L. E., Fujita, A., de Lecea, L., & Jackson, A. C. (2016) · The Journal of Physiology · doi:10.1113/jp271946 · Cited by 271
“A majority of Hcrt/Ox neurons co-express the neuropeptide dynorphin (Dyn) (Chou et al., 2001; Muschamp et al, 2014).”
Background
Metadata
- Authors
- Muschamp, J. W., Hollander, J. A., Thompson, J. L., Voren, G., Hassinger, L. C., Onvani, S., Kamenecka, T. M., Borgland, S. L., Kenny, P. J., & Carlezon, W. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-03-24
- Volume
- 111
- Issue
- 16
- Pages
- E1648-55
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2065585794
- Cited by
- 256
- References
- 55
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.